Related Topics
How Massachusetts will roll out COVID-19 vaccines
Frontline health care workers, residents of nursing homes and long-term-care facilities, emergency workers, and staff and residents of prisons and homeless shelters will be among the first to receive COVID-19 vaccinations in Massachusetts.
A call for concerted action on COVID-19
A group of experts in health, education and the economy is calling for common, comprehensive action across U.S. states to fight COVID-19.
Atul Gawande discusses COVID-19 vaccine challenges
Atul Gawande spoke about vaccines and other issues surrounding COVID-19 in an interview with New Yorker editor David Remnick.
Expert frustrated at lack of rapid at-home COVID-19 tests
Harvard Chan School's Michael Mina urged people to pressure their legislators to work on getting approval for rapid paper-strip COVID-19 tests that can be used at home.
How long until you can get a COVID-19 vaccine?
A December 3, 2020 New York Times article offers a fill-in-the-blanks form for figuring out what your place in line might be to get vaccinated against the coronavirus.
Experts discuss vaccine hesitancy and COVID-19
A panel of experts discussed how to restore public confidence in vaccines at a November 17, 2020 event hosted by the Human Immunomics Initiative.
COVID Collaborative, Ad Council launch vaccine education campaign
A massive public education campaign is underway to convince people to get vaccinated against COVID-19.
Efforts to increase HPV vaccine use are cost effective
Three types of interventions aimed at increasing human papillomavirus (HPV) vaccine coverage are all cost-effective.
‘A terrific first start’
Barry Bloom offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus.
Op-ed: Public health leaders can build public support for a COVID-19 vaccine
With recent surveys suggesting that many Americans may be reluctant to take a COVID-19 vaccine once it’s available, it will be important for public health leaders to reduce fear and build public support for a vaccine.
